Pharmacy owners that are offering the Lateral Flow Device (LFD) service may want to consider approaching their local care homes to see if they would like to access free LFD test kits, ahead of the start of autumn, for those people eligible for the service. All people aged 85 years and over are eligible for [...]
The post LFD service: Promoting the service to care homes appeared first on Community Pharmacy England.
In response to a significant ongoing disruption to the supply of Cefalexin 500mg tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 6 August 2024, SSP072 provides that for every Cefalexin 500mg tablet originally prescribed one Cefalexin 500mg capsule must be supplied. SSP072, authorised by the Secretary [...]
The post New SSP issued for Cefalexin 500mg tablets (SSP072) appeared first on Community Pharmacy England.
Update 15/11/24 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Ramipril 2.5mg tablets (SSP071) was due to expire 15 November 2024 but has been further extended to Friday 29 November 2024. Community Pharmacy England’s in-house Drug Tariff and funding experts have created a [...]
The post SSP071 – Ramipril 2.5mg tablets extended appeared first on Community Pharmacy England.
Protests and violent disorder are affecting some towns and cities across England and this may have an impact on the ability of community pharmacies to operate. If your pharmacy is in an area which is being affected by protests, follow any guidance being provided by the police or local government to protect yourself, staff, patients [...]
The post Protest activity across England: impact on pharmacies appeared first on Community Pharmacy England.
MSD UK in agreement with the Medicines and Healthcare product Regulatory Agency (MHRA) has announced an extension to the shelf-life of of certain batches of Lagevrio® (molnupiravir) 200 mg hard capsules beyond the labelled expiry date by 6, 12 or 18 months. This extension is based on supportive stability data for Lagevrio® which has been [...]
The post Lagevrio® (molnupiravir) 200 mg hard capsules – shelf life extension appeared first on Community Pharmacy England.
Recent Comments